Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NIH-funded observational study shows cardiovascular risk grows sharply with more frequent use.
A recent study of people with HIV showed that a daily statin lowers the risk for heart attacks and other cardiovascular events.
Study finds that even when women and men get the same amount of physical activity, the risk of premature death is lower for women.
Updated guidance is based on findings from the REPRIEVE trial, which showed pitavastatin reduced the risk of cardiovascular events by 35%.
The COVID virus infected coronary arteries and increased inflammation in atherosclerotic plaques.
NIH-funded research sheds light on link between COVID-19 and increased risk of cardiovascular disease and stroke.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
Statins reduce low-density lipoprotein (LDL) cholesterol and also have anti-inflammatory properties.
Certain drugs in this class may increase the likelihood of diabetes and hypertension, but cardiovascular risk factors can be managed.
Conversations on reducing cardiovascular disease among people with HIV and long-acting prevention and treatment options.
REPRIEVE trial finds pitavastatin reduced the risk for heart attack, stroke and other major cardiovascular events by 35%.
A large body of research has shown that people living with HIV are at greater risk for cardiovascular disease.
Among people 65 and older, cardiovascular deaths plunged 22% between 1999 and 2010 -- but then climbed 13% between 2011 and 2019.
Large trial finds that pitavastatin lowered the risk for major cardiovascular events by 35%.
People starting on integrase inhibitors were no more likely to have heart attacks, strokes or cardiovascular procedures.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.